This study will be conducted to compare the efficacy and safety of Trospium chloride versus Tamsulosin for treatment of ureteral stent related symptoms.
Eligible patients will be randomized to one of the two treatment groups. Group 1 patients will receive 30 mg of Trospium chloride tablet twice daily, while group 2 patients will receive 0.4 mg of Tamsulosin tablet once daily, until the stent is removed. Ureteral Stent Symptoms Questionnaire (USSQ) will be used to evaluate the symptoms of the patients with DJ stent after 2 weeks of inserting the stent.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
200
30 mg of Trospium chloride tablet twice daily
0.4 mg of Tamsulosin tablet once daily
Ahmed R EL-Nahas
Al Mansurah, Kuwait, Egypt
Ureteral Stent Symptoms Questionnaire (USSQ) score
Quantitative assessment of quality of life score
Time frame: 14 days
Adverse events
Assessment of side effects of the drug used
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.